# Rhophylac

NDC: 44206-300
Generic name: HUMAN RHO(D) IMMUNE GLOBULIN
Labeler / Manufacturer: CSL Behring AG
Product type: PLASMA DERIVATIVE
Marketing category: Biologic License Application
Dosage form: SOLUTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20090106

FDA application: BLA125070

## Active ingredients

- HUMAN RHO(D) IMMUNE GLOBULIN: 1500 [iU]/2mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"44206-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=44206-300